Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1082-1087, May 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schröder, J.
Right arrow Articles by Plagemann, P. G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schröder, J.
Right arrow Articles by Plagemann, P. G. W.

Cyclic 3',5'-Nucleotide Phosphodiesterases of Novikoff Rat Hepatoma, Mouse L, and HeLa Cells Growing in Suspension Culture1

Joachim Schröder and Peter G. W. Plagemann

Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, and the Division of Research, National Jewish Hospital and Research Center, Denver, Colorado 80206

Cultured Novikoff rat hepatoma, human HeLa, and mouse L cells contain 2 cyclic 3',5'-nucleotide phosphodiesterases, 1 with a low apparent Km of 1 to 2 {varepsilon}M for cyclic 3',5'-monophosphate and another with an apparent Km of 100 to 400 {varepsilon}M. The high-Km phosphodiesterases are inhibited by theophylline in a simple, competitive manner, whereas the low-Km enzymes are inhibited in a noncompetitive manner, although the Ki's of inhibition are similar for both activities (1 to 7 mM). For cell extracts from all 3 cell lines, specific activities for the low-Km phosphodiesterase are similar, although there is slightly higher activity in extracts of the fastest-growing Novikoff cells than in extracts from the other cell lines. In contrast, the specific activity for the high-Km phosphodiesterase is 30 to 40 times higher in L than in Novikoff cell extracts and intermediate in HeLa cell extracts, and in Novikoff cells there is only 5 to 10% as much activity as in rat liver. The specific activities for the 2 phosphodiesterases do not change significantly during the growth cycle in suspension culture.

1 Supported by USPHS Research Grant AI 07250 from the National Institute of Allergy and Infectious Diseases.

Received 12/20/71. Accepted 2/16/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.